<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36929812</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2470-9239</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Epilepsia open</Title><ISOAbbreviation>Epilepsia Open</ISOAbbreviation></Journal><ArticleTitle>The genetic link between systemic autoimmune disorders and temporal lobe epilepsy: A bioinformatics study.</ArticleTitle><Pagination><StartPage>509</StartPage><EndPage>516</EndPage><MedlinePgn>509-516</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/epi4.12727</ELocationID><Abstract><AbstractText Label="OBJECTIVE">We aimed to explore the underlying pathomechanisms of the comorbidity between three common systemic autoimmune disorders (SADs) [i.e., insulin-dependent diabetes mellitus (IDDM), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA)] and temporal lobe epilepsy (TLE), using bioinformatics tools. We hypothesized that there are shared genetic variations among these four conditions.</AbstractText><AbstractText Label="METHODS">Different databases (DisGeNET, Harmonizome, and Enrichr) were searched to find TLE-associated genes with variants; their single nucleotide polymorphisms (SNPs) were gathered from the literature. We also did a separate literature search using PubMed with the following keywords for original articles: "TLE" or "Temporal lobe epilepsy" AND "genetic variation," "single nucleotide polymorphism," "SNP," or "genetic polymorphism." In the next step, the SNPs associated with TLE were searched in the LitVar database to find the shared gene variations with RA, SLE, and IDDM.</AbstractText><AbstractText Label="RESULTS">Ninety unique SNPs were identified to be associated with TLE. LitVar search identified two SNPs that were shared between TLE and all three SADs (i.e., IDDM, SLE, and RA). The first SNP was rs16944 on the Interleukin-1&#x3b2; (IL-1&#x3b2;) gene. The second genetic variation was &#x3b5;4 variation of apolipoprotein E (APOE) gene.</AbstractText><AbstractText Label="SIGNIFICANCE">The shared genetic variations (i.e., rs16944 on the IL-1&#x3b2; gene and &#x3b5;4 variation of the APOE gene) may explain the underlying pathomechanisms of the comorbidity between three common SADs (i.e., IDDM, SLE, and RA) and TLE. Exploring such shared genetic variations may help find targeted therapies for patients with TLE, especially those with drug-resistant seizures who also have comorbid SADs.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malekpour</LastName><ForeName>Mahdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salarikia</LastName><ForeName>Seyed Reza</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kashkooli</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asadi-Pooya</LastName><ForeName>Ali A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-2598-7601</Identifier><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Epilepsia Open</MedlineTA><NlmUniqueID>101692036</NlmUniqueID><ISSNLinking>2470-9239</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004833" MajorTopicYN="Y">Epilepsy, Temporal Lobe</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013702" MajorTopicYN="N">Temporal Lobe</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoimmune</Keyword><Keyword MajorTopicYN="N">epilepsy</Keyword><Keyword MajorTopicYN="N">gene</Keyword><Keyword MajorTopicYN="N">seizure</Keyword></KeywordList><CoiStatement>Ali A. Asadi&#x2010;Pooya: Honoraria from Cobel Daruo, Ronak, and RaymandRad; Royalty: Oxford University Press (Book publication); grant from the National Institute for Medical Research Development. Mahdi Malekpour, Seyed Reza Salarikia, Mohammad Kashkooli: none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>17</Day><Hour>10</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36929812</ArticleId><ArticleId IdType="pmc">PMC10235559</ArticleId><ArticleId IdType="doi">10.1002/epi4.12727</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Asadi&#x2010;Pooya AA, Stewart GR, Abrams DJ, Sharan A. Prevalence and incidence of drug&#x2010;resistant mesial temporal lobe epilepsy in the United States. World Neurosurg. 2017;99:662&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28034810</ArticleId></ArticleIdList></Reference><Reference><Citation>You J, Huang H, Chan CTY, Li L. Pathological Targets for Treating Temporal Lobe Epilepsy: Discoveries From Microscale to Macroscale. Front Neurol. 2022;12:779558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8777077</ArticleId><ArticleId IdType="pubmed">35069411</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi&#x2010;Pooya AA, Farazdaghi M. Clinical characteristics of MRI&#x2010;negative temporal lobe epilepsy. Acta Neurol Belg. 2022. 10.1007/s13760-022-02145-2. Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-022-02145-2</ArticleId><ArticleId IdType="pubmed">36385248</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhlhofer W, Tan YL, Mueller SG, Knowlton R. MRI&#x2010;negative temporal lobe epilepsy&#x2010;what do we know? Epilepsia. 2017;58(5):727&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">28266710</ArticleId></ArticleIdList></Reference><Reference><Citation>Wie B&#xf8;rsheim A, Engeland A, Gilhus NE. Epilepsy and autoimmune diseases: comorbidity in a national patient cohort. Seizure. 2020;75:89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">31918165</ArticleId></ArticleIdList></Reference><Reference><Citation>Keezer MR, Novy J, Sander JW. Type 1 diabetes mellitus in people with pharmacoresistant epilepsy: prevalence and clinical characteristics. Epilepsy Res. 2015;115:55&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26220376</ArticleId></ArticleIdList></Reference><Reference><Citation>Giometto B, Nicolao P, Macucci M, Tavolato B, Foxon R, Bottazzo G. Temporal&#x2010;lobe epilepsy associated with glutamic&#x2010;acid&#x2010;decarboxylase autoantibodies. Lancet. 1998;352(9126):457.</Citation><ArticleIdList><ArticleId IdType="pubmed">9708763</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu HH, Lee JH, Wang LC, Yang YH, Chiang BL. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20&#x2010;year study. Lupus. 2006;15(10):651&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17120591</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanly JG, Urowitz MB, Su L, Gordon C, Bae SC, Sanchez&#x2010;Guerrero J, et al. Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study. Ann Rheum Dis. 2012;71(9):1502&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4656036</ArticleId><ArticleId IdType="pubmed">22492779</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Z, Si Q, Xiaoyi Z. Association between epilepsy and systemic autoimmune diseases: a meta&#x2010;analysis. Seizure. 2016;41:160&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27592469</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyota T, Akamatsu N, Tanaka A, Shouzaki T, Tsuji S, Saito K, et al. Mesial temporal lobe epilepsy as a neuropsychiatric syndrome of systemic lupus erythematosus. Epilepsia. 2013;54(3):e33&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">23126460</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Li S, Xie M, Chen R, Lu H, Wen C, et al. Risk of epilepsy in rheumatoid arthritis: a meta&#x2010;analysis of population based studies and bioinformatics analysis. Therapeutic Advances in Chronic Disease. 2020;11:2040622319899300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7011323</ArticleId><ArticleId IdType="pubmed">32095225</ArticleId></ArticleIdList></Reference><Reference><Citation>Rom AL, Wu CS, Olsen J, Jawaheer D, Hetland ML, Christensen J, et al. Parental rheumatoid arthritis and childhood epilepsy: a nationwide cohort study. Neurology. 2016;87(24):2510&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5206999</ArticleId><ArticleId IdType="pubmed">27856781</ArticleId></ArticleIdList></Reference><Reference><Citation>Daif A, Lukas RV, Issa NP, Javed A, VanHaerents S, Reder AT, et al. Antiglutamic acid decarboxylase 65 (GAD65) antibody&#x2010;associated epilepsy. Epilepsy Behav. 2018;80:331&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29433947</ArticleId></ArticleIdList></Reference><Reference><Citation>Valencia I. Epilepsy in systemic autoimmune disorders. Semin Pediatr Neurol; 2014;21(3):226&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">25510945</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MA, Alam F, Cavestro C, Calcii C, Sasongko TH, Levy RA, et al. Antiphospholipid antibodies in epilepsy: a systematic review and meta&#x2010;analysis. Autoimmun Rev. 2018;17(8):755&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">29885542</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey A, Kang X, Qiu J, Du Y, Jiang J. Anti&#x2010;inflammatory small molecules to treat seizures and epilepsy: from bench to bedside. Trends Pharmacol Sci. 2016;37(6):463&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5064857</ArticleId><ArticleId IdType="pubmed">27062228</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou&#x2010;Khalil B, Auce P, Avbersek A, Bahlo M, Balding DJ, Bast T, et al. Genome&#x2010;wide mega&#x2010;analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies. Nat Commun. 2018;9(1):5269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6288131</ArticleId><ArticleId IdType="pubmed">30531953</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi&#xf1;ero J, Ram&#xed;rez&#x2010;Anguita JM, Sa&#xfc;ch&#x2010;Pitarch J, Ronzano F, Centeno E, Sanz F, et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 2019;48(D1):D845&#x2013;D55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7145631</ArticleId><ArticleId IdType="pubmed">31680165</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD, McDermott MG, et al. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database. 2016;2016:baw100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4930834</ArticleId><ArticleId IdType="pubmed">27374120</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, et al. Gene set knowledge discovery with Enrichr. Current Protocols. 2021;1(3):e90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8152575</ArticleId><ArticleId IdType="pubmed">33780170</ArticleId></ArticleIdList></Reference><Reference><Citation>Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, et al. The NHGRI&#x2010;EBI GWAS catalog of published genome&#x2010;wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47(D1):D1005&#x2013;D12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323933</ArticleId><ArticleId IdType="pubmed">30445434</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei CH, Phan L, Feltz J, Maiti R, Hefferon T, Lu Z. tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVar for precision medicine. Bioinformatics. 2018;34(1):80&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5860583</ArticleId><ArticleId IdType="pubmed">28968638</ArticleId></ArticleIdList></Reference><Reference><Citation>Allot A, Peng Y, Wei CH, Lee K, Phan L, Lu Z. LitVar: a semantic search engine for linking genomic variant data in PubMed and PMC. Nucleic Acids Res. 2018;46(W1):W530&#x2013;w6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6030971</ArticleId><ArticleId IdType="pubmed">29762787</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal B, Chaves J, Carvalho C, Bettencourt A, Brito C, Boleixa D, et al. Immunogenetic predisposing factors for mesial temporal lobe epilepsy with hippocampal sclerosis. Int J Neurosci. 2018;128(4):305&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">28675059</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison P, Pointon J, Chapman K, Roddam A, Wordsworth B. Interleukin&#x2010;1 promoter region polymorphism role in rheumatoid arthritis: a meta&#x2010;analysis of IL&#x2010;1B&#x2010;511A/G variant reveals association with rheumatoid arthritis. Rheumatology. 2008;47(12):1768&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">18838388</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong H, He X, Wang L, Bai M, Jin T, Wang Y, et al. Association between IL1B polymorphisms and the risk of rheumatoid arthritis. Int Immunopharmacol. 2020;83:106401.</Citation><ArticleIdList><ArticleId IdType="pubmed">32240943</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashad NM, Soliman MH, El&#x2010;Shal AS, Said D, Samir GM. Effect of interleukin&#x2010;1&#x3b2; gene polymorphisms on clinicopathological features and disease activity of systemic lupus erythematosus. Egypt J Int Med. 2019;31(2):235&#x2013;42.</Citation></Reference><Reference><Citation>Luotola K, Paakkonen R, Alanne M, Lanki T, Moilanen L, Surakka I, et al. Association of variation in the interleukin&#x2010;1 gene family with diabetes and glucose homeostasis. J Clin Endocrinol Metabol. 2009;94(11):4575&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">19820020</ArticleId></ArticleIdList></Reference><Reference><Citation>Briellmann R, Torn&#x2010;Broers Y, Busuttil B, Major B, Kalnins R, Olsen M, et al. APOE &#x3b5;4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology. 2000;55(3):435&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10932283</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Ding C, Gong X, Wang X, Cui T. Apolipoprotein E &#x3b5;4 allele was associated with Nonlesional mesial temporal lobe epilepsy in Han Chinese population. Medicine. 2016;95(9):e2894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4782864</ArticleId><ArticleId IdType="pubmed">26945380</ArticleId></ArticleIdList></Reference><Reference><Citation>Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 1994;17(12):525&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">7532337</ArticleId></ArticleIdList></Reference><Reference><Citation>Toms TE, Smith JP, Panoulas VF, Blackmore H, Douglas KM, Kitas GD. Apolipoprotein E gene polymorphisms are strong predictors of inflammation and dyslipidemia in rheumatoid arthritis. J Rheumatol. 2012;39(2):218&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">22174202</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YM, Chen PK, Chang CK, Lin CC, Chen HH, Lan JL, et al. Association of Apolipoprotein E Polymorphism with Adipokines and cardiovascular disease risk in rheumatoid arthritis patients. Life. 2020;10(12):330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7762228</ArticleId><ArticleId IdType="pubmed">33297350</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanhapour M, Miri A, Vaisi&#x2010;Raygani A, Bahrehmand F, Kiani A, Rahimi Z, et al. Synergism between apolipoprotein E &#x190;4 allele and paraoxonase (PON1) 55&#x2010;M allele is associated with risk of systemic lupus erythematosus. Clin Rheumatol. 2018;37(4):971&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">29273831</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Rayes H, Huraib G, Julkhuf S, Arfin M, Tariq M, Al&#x2010;Asmari A. Apolipoprotein E Gene polymorphisms in saudi patients with systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord. 2016;9:81&#x2013;7. 10.4137/CMAMD.S38090</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/CMAMD.S38090</ArticleId><ArticleId IdType="pmc">PMC4877081</ArticleId><ArticleId IdType="pubmed">27257397</ArticleId></ArticleIdList></Reference><Reference><Citation>van Duinkerken E, Ijzerman RG, Barkhof F, Moll AC, Diamant M, Snoek FJ, et al. Cognitive functioning and hippocampal connectivity in patients with longstanding type 1 diabetes and Apolipoprotein E &#x3b5;4. Diabetes Care. 2021;44(10):2388&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">34380705</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedoni M, Hovnik T, Plesnik E, Kotnik P, Bratina N, Battelino T, et al. Metabolic control, ApoE genotypes, and dyslipidemia in children, adolescents and young adults with type 1 diabetes. Atherosclerosis. 2018;273:53&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29679801</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesraoua B, Deleu D, Al Hail HJ, Melikyan G, Abdalhalim Ali M, Haddad N, et al. Prevalence and incidence of drug&#x2010;resistant temporal lobe epilepsy in Qatar. J Cent Nerv Syst Dis. 2020;27(12):1179573520935031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323268</ArticleId><ArticleId IdType="pubmed">32636694</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi&#x2010;Pooya AA, Sperling MR. Clinical features of sudden unexpected death in epilepsy. J Clin Neurophysiol. 2009;26(5):297&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">19713869</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong LT. Temporal lobe epilepsy &#x2013; pathophysiology and mechanisms. Eur Neurol Rev. 2019;14:66.</Citation></Reference><Reference><Citation>Santos RO, Secolin R, Barbalho PG, Silva&#x2010;Alves MS, Alvim MKM, Yasuda CL, et al. Multidimensional approach assessing the role of interleukin 1 Beta in mesial temporal lobe epilepsy. Front Neurol. 2021;12(1237):690847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8375265</ArticleId><ArticleId IdType="pubmed">34421794</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall SK, Perregaux DG, Gabel CA, Woodworth T, Durham LK, Huizinga T, et al. Correlation of polymorphic variation in the promoter region of the interleukin&#x2010;1&#x3b2; gene with secretion of interleukin&#x2010;1&#x3b2; protein. Arthritis Rheum. 2004;50(6):1976&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">15188375</ArticleId></ArticleIdList></Reference><Reference><Citation>Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia. 2005;46(11):1724&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">16302852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanemoto K, Kawasaki J, Yuasa S, Kumaki T, Tomohiro O, Kaji R, et al. Increased frequency of interleukin&#x2010;1beta&#x2010;511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia. 2003;44(6):796&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12790892</ArticleId></ArticleIdList></Reference><Reference><Citation>Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, et al. Interleukin&#x2010;1beta enhances NMDA receptor&#x2010;mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci. 2003;23(25):8692&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6740426</ArticleId><ArticleId IdType="pubmed">14507968</ArticleId></ArticleIdList></Reference><Reference><Citation>Vezzani A, Viviani B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology. 2015;96:70&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">25445483</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang I&#x2010;R, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1&#x3b2; production in helicobacter pylori infection. Gastroenterology. 2002;123(6):1793&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pubmed">12454835</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao R, Zhou H, Su SB. A critical role for interleukin&#x2010;1&#x3b2; in the progression of autoimmune diseases. Int Immunopharmacol. 2013;17(3):658&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">24012439</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortis F, Pirot P, Naamane N, Kreins AY, Rasschaert J, Moore F, et al. Induction of nuclear factor&#x2010;&#x3ba;B and its downstream genes by TNF&#x2010;&#x3b1; and IL&#x2010;1&#x3b2; has a pro&#x2010;apoptotic role in pancreatic beta cells. Diabetologia. 2008;51(7):1213&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">18463842</ArticleId></ArticleIdList></Reference><Reference><Citation>Geranurimi A, Cheng CWH, Quiniou C, C&#xf4;t&#xe9; F, Hou X, Lahaie I, et al. Interleukin&#x2010;1 receptor modulation using &#x3b2;&#x2010;substituted &#x3b1;&#x2010;amino&#x2010;&#x3b3;&#x2010;lactam peptides from solid&#x2010;phase synthesis and diversification. Front Chem. 2020;21(8):610431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7783595</ArticleId><ArticleId IdType="pubmed">33415098</ArticleId></ArticleIdList></Reference><Reference><Citation>Vezzani A, Balosso S, Ravizza T. Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat Rev Neurol. 2019;15(8):459&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">31263255</ArticleId></ArticleIdList></Reference><Reference><Citation>Vezzani A, Auvin S, Ravizza T, Aronica E. Glia&#x2010;neuronal interactions in ictogenesis and epileptogenesis: role of inflammatory mediators. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado&#x2010;Escueta AV, editors. Jasper's basic mechanisms of the epilepsies [internet]. 4th ed. Bethesda (MD): National Center for Biotechnology Information (US); 2012. PMID: 22787662.</Citation><ArticleIdList><ArticleId IdType="pubmed">22787662</ArticleId></ArticleIdList></Reference><Reference><Citation>
https://www.arcalyst.com/sites/arcalyst.com/files/2021&#x2010;08/PI_IFU.pdf/. Accessed on 27 November, 2022.</Citation></Reference><Reference><Citation>Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin&#x2010;1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11(8):633&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3644509</ArticleId><ArticleId IdType="pubmed">22850787</ArticleId></ArticleIdList></Reference><Reference><Citation>
https://kineretrxhcp.com/pdf/Full&#x2010;Prescribing&#x2010;Information&#x2010;English.pdf/. Accessed on 7 December, 2022.</Citation></Reference><Reference><Citation>
https://www.novartis.com/us&#x2010;en/sites/novartis_us/files/ilaris.pdf/. Accessed on 7 December, 2022.</Citation></Reference><Reference><Citation>Bien&#x2010;Ly N, Gillespie AK, Walker D, Yoon SY, Huang Y. Reducing human apolipoprotein E levels attenuates age&#x2010;dependent A&#x3b2; accumulation in mutant human amyloid precursor protein transgenic mice. J Neurosci. 2012;32(14):4803&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3433173</ArticleId><ArticleId IdType="pubmed">22492035</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao F, Hori Y, Hudry E, Bauer AQ, Jiang H, Mahan TE, et al. Anti&#x2010;ApoE antibody given after plaque onset decreases A&#x3b2; accumulation and improves brain function in a mouse model of A&#x3b2; amyloidosis. J Neurosci. 2014;34(21):7281&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4028501</ArticleId><ArticleId IdType="pubmed">24849360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Eltorai AE, Jiang H, Liao F, Verghese PB, Kim J, et al. Anti&#x2010;apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of A&#x3b2; amyloidosis. J Exp Med. 2012;209(12):2149&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3501350</ArticleId><ArticleId IdType="pubmed">23129750</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamali S, Bartolomei F, Robaglia&#x2010;Schlupp A, Massacrier A, Peragut JC, R&#xe9;gis J, et al. Large&#x2010;scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex. Brain. 2006;129(Pt 3):625&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">16399808</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravizza T, Gagliardi B, No&#xe9; F, Boer K, Aronica E, Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis. 2008;29(1):142&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">17931873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong MS, Kohane IS, Cai T, Gorman MP, Mandl KD. Population&#x2010;level evidence for an autoimmune etiology of epilepsy. JAMA Neurol. 2014;71(5):569&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4324719</ArticleId><ArticleId IdType="pubmed">24687183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Duan C, Wang R, Chen L, Wang Y. Inflammation&#x2010;related genes and immune infiltration landscape identified in kainite&#x2010;induced temporal lobe epilepsy based on integrated bioinformatics analysis. Front Neurosci. 2022;16:996368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9648357</ArticleId><ArticleId IdType="pubmed">36389252</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>